CATEGORIES

Press Release

LATEST

TRENDING

EDITORS CHOICE

First Hospitals in U.S. Implant Next-gen Cardiac Device to Reduce Stroke Risk

The WATCHMAN FLX is the only FDA-approved device for the reduction of stroke risk in patients with non-valvular atrial fibrillation (A Fib).

Texas Food Relief with NCS Group and #BStrong Initiative Deliver Food Aid Across Texas

Each NCS Group Unlimited Carrier Fleet Vehicle brings a total of $180K+ worth of supplies and aid, and a total of six trucks are arriving in Texas

Never-Before-Seen COVID-19 Data Report Released by HHS

HHS has just released the "COVID Community Profile Report," a daily updated snapshot of how COVID-19 is affecting our states and communities

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients